Skip to main content

May 2013 - FRMC

Conference Insider
05/17/2013
Jill Sederstorm
San Diego—Medication nonadherence is a costly problem in healthcare, but predictive modeling, value-based insurance design (VBID), and the application of gamification could help improve adherence rates. These 3 strategies and the challenges...
San Diego—Medication nonadherence is a costly problem in healthcare, but predictive modeling, value-based insurance design (VBID), and the application of gamification could help improve adherence rates. These 3 strategies and the challenges...
San Diego—Medication...
05/17/2013
First Report Managed Care
Department
05/17/2013
Tim Casey
San Diego—In the past, patients with multiple sclerosis were required to administer medications intravenously or via injections, a painful process for some, but they had no other choices. Now, though, treatment options have expanded into oral...
San Diego—In the past, patients with multiple sclerosis were required to administer medications intravenously or via injections, a painful process for some, but they had no other choices. Now, though, treatment options have expanded into oral...
San Diego—In the past, patients...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013
Tim Casey
San Diego—As many as 6 million people in the United States are at risk of anaphylaxis, and the prevalence is increasing, especially among people <20 years of age, according to several studies. In August 2012, the FDA approved Auvi-Q™...
San Diego—As many as 6 million people in the United States are at risk of anaphylaxis, and the prevalence is increasing, especially among people <20 years of age, according to several studies. In August 2012, the FDA approved Auvi-Q™...
San Diego—As many as 6 million...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013
Tori Socha
San Diego—There are approximately 7000 diseases that are categorized as rare, but only 5% of those have approved treatments. The 1984 amendment to the Orphan Drug Act of 1983 (ODA) defined a rare disease as one that affects 200,000 people in...
San Diego—There are approximately 7000 diseases that are categorized as rare, but only 5% of those have approved treatments. The 1984 amendment to the Orphan Drug Act of 1983 (ODA) defined a rare disease as one that affects 200,000 people in...
San Diego—There are...
05/17/2013
First Report Managed Care
05/17/2013
Tori Socha
San Diego—In March 2012, the U.S. Department of Health & Human Services (HHS) issued guidelines for the use of antiretroviral therapy (ART) in patients with HIV that recommend 4 specific preferred ART regimens for ART-naïve patients.
San Diego—In March 2012, the U.S. Department of Health & Human Services (HHS) issued guidelines for the use of antiretroviral therapy (ART) in patients with HIV that recommend 4 specific preferred ART regimens for ART-naïve patients.
San Diego—In March 2012, the...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013
Tim Casey
San Diego—With major provisions from the Patient Protection and Affordable Care Act becoming effective next year, the healthcare industry is facing a challenge keeping medication costs in check due to, in part, the proliferation of expensive...
San Diego—With major provisions from the Patient Protection and Affordable Care Act becoming effective next year, the healthcare industry is facing a challenge keeping medication costs in check due to, in part, the proliferation of expensive...
San Diego—With major provisions...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013
Mary Beth Nierengarten
San Diego—With the dominance of specialty drugs driving increasing prescription medication expenditures, pharmacists need to prepare for significant growth in specialty pharmaceuticals and its impact on medication benefit plans.
San Diego—With the dominance of specialty drugs driving increasing prescription medication expenditures, pharmacists need to prepare for significant growth in specialty pharmaceuticals and its impact on medication benefit plans.
San Diego—With the dominance of...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013
Tori Socha
San Diego—Pain is challenging to treat and the healthcare cost burden of pain is substantial. According to researchers, understanding the dynamics of the economic burden of pain will help providers and payers allocate resources more...
San Diego—Pain is challenging to treat and the healthcare cost burden of pain is substantial. According to researchers, understanding the dynamics of the economic burden of pain will help providers and payers allocate resources more...
San Diego—Pain is challenging to...
05/17/2013
First Report Managed Care
05/17/2013
Tori Socha
San Diego—Healthcare decision makers face challenges in optimizing disease management in patients with type 2 diabetes mellitus (T2DM). Increasing healthcare expenditures can be attributed, in part, to the costs, including medical and...
San Diego—Healthcare decision makers face challenges in optimizing disease management in patients with type 2 diabetes mellitus (T2DM). Increasing healthcare expenditures can be attributed, in part, to the costs, including medical and...
San Diego—Healthcare decision...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013
Tori Socha
San Diego—Multiple sclerosis generally presents in young adults, resulting in a greater loss of productivity and quality of life compared with other diseases. Frequency of relapses can be reduced with use of disease-modifying drugs (DMDs),...
San Diego—Multiple sclerosis generally presents in young adults, resulting in a greater loss of productivity and quality of life compared with other diseases. Frequency of relapses can be reduced with use of disease-modifying drugs (DMDs),...
San Diego—Multiple sclerosis...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013
Tori Socha
San Diego—The annual prevalence of major depressive disorder (MDD) in the United States is 7% and the lifetime prevalence rate is 16%. Patients with MDD experience depressed mood, fatigue, lack of interest in activities, insomnia or...
San Diego—The annual prevalence of major depressive disorder (MDD) in the United States is 7% and the lifetime prevalence rate is 16%. Patients with MDD experience depressed mood, fatigue, lack of interest in activities, insomnia or...
San Diego—The annual prevalence...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013
Tori Socha
San Diego—According to researchers, declining health plan reimbursements for physician-administered chemotherapy may shift the population of oncology patients treated with infused chemotherapy from office/clinic settings to outpatient...
San Diego—According to researchers, declining health plan reimbursements for physician-administered chemotherapy may shift the population of oncology patients treated with infused chemotherapy from office/clinic settings to outpatient...
San Diego—According to...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013
Mary Mihalovic
San Diego—Existing healthcare decision models may not always address real-world needs of decision makers, according to information presented during a Contemporary Issues session at the AMCP meeting titled Adapting Decision Analytic Models to...
San Diego—Existing healthcare decision models may not always address real-world needs of decision makers, according to information presented during a Contemporary Issues session at the AMCP meeting titled Adapting Decision Analytic Models to...
San Diego—Existing healthcare...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013
Tori Socha
According to statistics from the CDC, nonmedical use of prescription drugs is the second leading cause of accidental death in the US.
According to statistics from the CDC, nonmedical use of prescription drugs is the second leading cause of accidental death in the US.
According to statistics from the...
05/17/2013
First Report Managed Care
05/17/2013
Tori Socha
San Diego—Compared with other chronic conditions, national trends indicate that adherence to medications to treat overactive bladder (OAB) is relatively poor. Antimuscarinic medications, including oxybutynin, are commonly prescribed for OAB....
San Diego—Compared with other chronic conditions, national trends indicate that adherence to medications to treat overactive bladder (OAB) is relatively poor. Antimuscarinic medications, including oxybutynin, are commonly prescribed for OAB....
San Diego—Compared with other...
05/17/2013
First Report Managed Care
05/17/2013
Eileen Koutnik-Fotopoulos
San Diego—Diabetes patients treated with saxagliptin were significantly less prone to inpatient hospitalizations or emergency department (ED) visits than patients treated with sulfonylureas. Total healthcare costs were also lower for the...
San Diego—Diabetes patients treated with saxagliptin were significantly less prone to inpatient hospitalizations or emergency department (ED) visits than patients treated with sulfonylureas. Total healthcare costs were also lower for the...
San Diego—Diabetes patients...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013
Kevin L. Carter
San Diego—The federal budget sequester struggle, the continuing movement toward the implementation of the Patient Protection and Affordable Care Act (ACA), and issues facing Medicare Part D are among the most significant legislative and...
San Diego—The federal budget sequester struggle, the continuing movement toward the implementation of the Patient Protection and Affordable Care Act (ACA), and issues facing Medicare Part D are among the most significant legislative and...
San Diego—The federal budget...
05/17/2013
First Report Managed Care
05/17/2013
Jill Sederstorm
San Diego—A new retrospective analysis of patients suffering from migraines found that the use of triptans did not decrease the utilization of healthcare resources, and, in some cases, was associated with an increase in utilization. These...
San Diego—A new retrospective analysis of patients suffering from migraines found that the use of triptans did not decrease the utilization of healthcare resources, and, in some cases, was associated with an increase in utilization. These...
San Diego—A new retrospective...
05/17/2013
First Report Managed Care
05/17/2013
Eileen Koutnik-Fotopoulos
San Diego—Currently, health plans are designing pharmacy benefits to be used in conjunction with the medical benefits for the state health exchanges. Successful health plans will engage pharmacists to improve the design and management of the...
San Diego—Currently, health plans are designing pharmacy benefits to be used in conjunction with the medical benefits for the state health exchanges. Successful health plans will engage pharmacists to improve the design and management of the...
San Diego—Currently, health...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013
Tori Socha
San Diego—Accountable care organizations (ACOs), included as part of the Patient Protection and Affordable Care Act, are groups of physicians, hospitals, and other healthcare providers who form an organization to provide coordinated quality...
San Diego—Accountable care organizations (ACOs), included as part of the Patient Protection and Affordable Care Act, are groups of physicians, hospitals, and other healthcare providers who form an organization to provide coordinated quality...
San Diego—Accountable care...
05/17/2013
First Report Managed Care
05/17/2013
Tori Socha
San Diego—The emerging model for healthcare in the United States is value-driven healthcare, according to speakers at a Contemporary Issues session at the AMCP meeting. The session was titled How Much of the $3 Billion in Star Rating Bonuses...
San Diego—The emerging model for healthcare in the United States is value-driven healthcare, according to speakers at a Contemporary Issues session at the AMCP meeting. The session was titled How Much of the $3 Billion in Star Rating Bonuses...
San Diego—The emerging model for...
05/17/2013
First Report Managed Care
05/17/2013
Kevin L. Carter
San Diego—Despite clinical practice that usually does not include the introduction of insulin therapy in patients newly diagnosed with type 2 diabetes mellitus (T2DM), most patients will eventually require treatment with insulin to maintain...
San Diego—Despite clinical practice that usually does not include the introduction of insulin therapy in patients newly diagnosed with type 2 diabetes mellitus (T2DM), most patients will eventually require treatment with insulin to maintain...
San Diego—Despite clinical...
05/17/2013
First Report Managed Care
05/17/2013
Mary Mihalovic
San Diego—The challenges that come with the launch of the new health insurance marketplaces as 2014 rapidly approaches were topic for discussion in a Contemporary Issues session at the AMCP meeting titled Fostering Healthy Markets:...
San Diego—The challenges that come with the launch of the new health insurance marketplaces as 2014 rapidly approaches were topic for discussion in a Contemporary Issues session at the AMCP meeting titled Fostering Healthy Markets:...
San Diego—The challenges that...
05/17/2013
First Report Managed Care
05/17/2013
Kevin L. Carter
San Diego—Many companies that supply insulin can offer products with similar pharmacokinetic or pharmacodynamic (PK/PD) properties. This is the case with the active ingredients of insulin products produced by Eli Lilly and Company (LLY) and...
San Diego—Many companies that supply insulin can offer products with similar pharmacokinetic or pharmacodynamic (PK/PD) properties. This is the case with the active ingredients of insulin products produced by Eli Lilly and Company (LLY) and...
San Diego—Many companies that...
05/17/2013
First Report Managed Care
05/17/2013
Kevin L. Carter
San Diego—The best time for a physician and patient to decide on an effective, comprehensive, and manageable treatment plan is during the initial prescribing visit. This is, according to a Contemporary Issues session at the AMCP meeting, the...
San Diego—The best time for a physician and patient to decide on an effective, comprehensive, and manageable treatment plan is during the initial prescribing visit. This is, according to a Contemporary Issues session at the AMCP meeting, the...
San Diego—The best time for a...
05/17/2013
First Report Managed Care
05/17/2013
Jill Sederstorm
San Diego—The cost of care has significantly increased for Medicare patients taking leucovorin and/or Fusilev® (levoleucovorin) since the first leucovorin shortage in 2008, according to findings from a recent retrospective analysis presented...
San Diego—The cost of care has significantly increased for Medicare patients taking leucovorin and/or Fusilev® (levoleucovorin) since the first leucovorin shortage in 2008, according to findings from a recent retrospective analysis presented...
San Diego—The cost of care has...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013
Jill Sederstorm
San Diego—The Medicaid patient population is expected to grow under the Patient Protection and Affordable Care Act (ACA), leaving managed care organizations (MCOs) to face increasing challenges as they attempt to limit costs, particularly in...
San Diego—The Medicaid patient population is expected to grow under the Patient Protection and Affordable Care Act (ACA), leaving managed care organizations (MCOs) to face increasing challenges as they attempt to limit costs, particularly in...
San Diego—The Medicaid patient...
05/17/2013
First Report Managed Care
05/17/2013
Eileen Koutnik-Fotopoulos
San Diego—An understanding of the current usage patterns of infliximab in the treatment of rheumatoid arthritis (RA) is a crucial component in the management of patients. Because real-world data of weight-based utilization patterns of this...
San Diego—An understanding of the current usage patterns of infliximab in the treatment of rheumatoid arthritis (RA) is a crucial component in the management of patients. Because real-world data of weight-based utilization patterns of this...
San Diego—An understanding of...
05/17/2013
First Report Managed Care
05/17/2013
Tori Socha
San Diego—Engaging patients and improving medication adherence was the aim of a program implemented in a population of dual-eligible special needs Medicare Advantage (MA) beneficiaries. The program involved the cooperation of a MA plan...
San Diego—Engaging patients and improving medication adherence was the aim of a program implemented in a population of dual-eligible special needs Medicare Advantage (MA) beneficiaries. The program involved the cooperation of a MA plan...
San Diego—Engaging patients and...
05/17/2013
First Report Managed Care
05/17/2013
Mary Beth Nierengarten
Based on a new claims-based algorithm developed to evaluate the effectiveness of biologics for rheumatoid arthritis (RA), self-injected subcutaneous (SC) first-line biologic agents are more effective than intravenous (IV) administered agents...
Based on a new claims-based algorithm developed to evaluate the effectiveness of biologics for rheumatoid arthritis (RA), self-injected subcutaneous (SC) first-line biologic agents are more effective than intravenous (IV) administered agents...
Based on a new claims-based...
05/17/2013
First Report Managed Care
05/17/2013
Mary Beth Nierengarten
Personalized medicine is promising to revolutionize medical care by tailoring diagnostic and therapeutic approaches to individual patients based on an improved understanding of genetics and molecular biology.
Personalized medicine is promising to revolutionize medical care by tailoring diagnostic and therapeutic approaches to individual patients based on an improved understanding of genetics and molecular biology.
Personalized medicine is...
05/17/2013
First Report Managed Care
05/17/2013
Mary Beth Nierengarten
More than a quarter of patients with HIV treated with antiretroviral therapy (ART) do not adhere to therapy, according to a study presented during a poster session at the AMCP meeting.
More than a quarter of patients with HIV treated with antiretroviral therapy (ART) do not adhere to therapy, according to a study presented during a poster session at the AMCP meeting.
More than a quarter of patients...
05/17/2013
First Report Managed Care
05/17/2013
Eileen Koutnik-Fotopoulos
The Centers for Medicare & Medicaid Services (CMS) Star Ratings program has heightened plan sponsors’ attention for the need to improve medication adherence and other aspects of medication use.
The Centers for Medicare & Medicaid Services (CMS) Star Ratings program has heightened plan sponsors’ attention for the need to improve medication adherence and other aspects of medication use.
The Centers for Medicare &...
05/17/2013
First Report Managed Care
05/17/2013
Mary Mihalovic
Switching oral contraceptive (OC) users to a low-dose levonorgestrel-intrauterine (LNG-IUS) system may result in overall cost savings for healthcare plans, due to subsequent decreases in pharmacy costs and a decrease in medical costs related...
Switching oral contraceptive (OC) users to a low-dose levonorgestrel-intrauterine (LNG-IUS) system may result in overall cost savings for healthcare plans, due to subsequent decreases in pharmacy costs and a decrease in medical costs related...
Switching oral contraceptive...
05/17/2013
First Report Managed Care
News
05/17/2013
Tim Casey
In the United States, approximately 400,000 people have multiple sclerosis (MS). Each day, there are approximately 200 new diagnoses of the disease, presenting a burden on patients who typically live with MS for 20 to 40 years as well as the...
In the United States, approximately 400,000 people have multiple sclerosis (MS). Each day, there are approximately 200 new diagnoses of the disease, presenting a burden on patients who typically live with MS for 20 to 40 years as well as the...
In the United States,...
05/17/2013
First Report Managed Care
05/17/2013
Tim Casey
Between 2007 and 2011, specialty drug costs grew from 15% to 20% each year, whereas spending on traditional drugs increased <5% each year, according to the Express Scripts 2011 drug trend report.
Between 2007 and 2011, specialty drug costs grew from 15% to 20% each year, whereas spending on traditional drugs increased <5% each year, according to the Express Scripts 2011 drug trend report.
Between 2007 and 2011, specialty...
05/17/2013
First Report Managed Care
05/17/2013
Mary Mihalovic
Patients with nonmetastatic HER2+ breast cancer who were administered trastuzumab in an outpatient hospital setting incurred higher total monthly healthcare costs compared with patients treated in an office clinic, according to information...
Patients with nonmetastatic HER2+ breast cancer who were administered trastuzumab in an outpatient hospital setting incurred higher total monthly healthcare costs compared with patients treated in an office clinic, according to information...
Patients with nonmetastatic...
05/17/2013
First Report Managed Care
05/17/2013
Tim Casey
San Diego—For managed care professionals, rheumatoid arthritis (RA) is among the most expensive and difficult diseases to manage. The FDA has approved several drugs to treat the disease, but it is sometimes hard to determine the option that...
San Diego—For managed care professionals, rheumatoid arthritis (RA) is among the most expensive and difficult diseases to manage. The FDA has approved several drugs to treat the disease, but it is sometimes hard to determine the option that...
San Diego—For managed care...
05/17/2013
First Report Managed Care
05/17/2013
Tori Socha
The Medicaid system includes patients described as complex, who comprise a challenging and transient group of patients. 
The Medicaid system includes patients described as complex, who comprise a challenging and transient group of patients. 
The Medicaid system includes...
05/17/2013
First Report Managed Care
News
05/17/2013
Tim Casey
As the FDA approves more drugs to treat multiple sclerosis, healthcare professionals are attempting to understand the costs, benefits, and risks associated with the various treatment options.
As the FDA approves more drugs to treat multiple sclerosis, healthcare professionals are attempting to understand the costs, benefits, and risks associated with the various treatment options.
As the FDA approves more drugs...
05/17/2013
First Report Managed Care
05/17/2013
Tim Casey
San Diego—For the first time in 60 years, prescription drug sales declined in the United States in 2012, falling by 1%. At the same time, the number of prescriptions filled increased only 1.2% last year, according to data from IMS Health, a...
San Diego—For the first time in 60 years, prescription drug sales declined in the United States in 2012, falling by 1%. At the same time, the number of prescriptions filled increased only 1.2% last year, according to data from IMS Health, a...
San Diego—For the first time in...
05/17/2013
First Report Managed Care
05/17/2013
Tim Casey
San Diego—The FDA approvals of boceprevir and telaprevir in 2011 were seen as breakthroughs in treating patients with hepatitis C. The oral drugs are protease inhibitors used in combination with pegylated interferon and ribavirin. These...
San Diego—The FDA approvals of boceprevir and telaprevir in 2011 were seen as breakthroughs in treating patients with hepatitis C. The oral drugs are protease inhibitors used in combination with pegylated interferon and ribavirin. These...
San Diego—The FDA approvals of...
05/17/2013
First Report Managed Care
05/17/2013
Tim Casey
Edith Rosato, RPh, began her position as AMCP’s chief executive officer in October 2011, coinciding with unprecedented change in the healthcare industry. Economic conditions were weak, and companies were preparing for provisions in the...
Edith Rosato, RPh, began her position as AMCP’s chief executive officer in October 2011, coinciding with unprecedented change in the healthcare industry. Economic conditions were weak, and companies were preparing for provisions in the...
Edith Rosato, RPh, began her...
05/17/2013
First Report Managed Care